KRAS and laryngotracheoesophageal cleft: Further tentative support for the efficacy of NK cells against lung cancer (LC) was derived from a laboratory investigation involving Kirsten rat sarcoma viral oncogene homolog (KRAS)-driven spontaneous LC and the implantation of cancer cells into mice [10].